 focal ischem damag cpp-ene studi anim model new high-affin competit n-methyl-d-aspart antagonist d-cpp-ene sdz-eaa model focal cerebr ischemia cat middl cerebr arteri occlus model hour surviv pretreat d-cpp-ene infarct size dose dose reduct infarct size dose mg/kg treatment hour occlus infarct size new model subdur hematoma rat zone cortic ischem damag blood clot d-cpp-ene pretreat neuroprotect efficaci gyrencephal speci compar noncompetit antagonist agent experi competit n-methyl-d-aspart antagonist use traumat intracrani hematoma